In a filing, Vor Biopharma Inc revealed its CHIEF MEDICAL OFFICER Attar Eyal C. unloaded Company’s shares for reported $20357.0 on Jun 03 ’24. In the deal valued at $1.39 per share,14,645 shares were sold. As a result of this transaction, Attar Eyal C. now holds 96,063 shares worth roughly $61480.32.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wedbush initiated its Vor Biopharma Inc [VOR] rating to an Outperform in a research note published on July 26, 2022; the price target was $18. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late April with a ‘”a Neutral”‘ rating. H.C. Wainwright began covering VOR with “Buy” recommendation on December 17, 2021. Robert W. Baird started covering the stock on December 03, 2021. It rated VOR as “an Outperform”.
Price Performance Review of VOR
On Tuesday, Vor Biopharma Inc [NASDAQ:VOR] saw its stock fall -3.04% to $0.64. Over the last five days, the stock has lost -5.39%. Vor Biopharma Inc shares have fallen nearly -71.36% since the year began. Nevertheless, the stocks have fallen -73.15% over the past one year. While a 52-week high of $3.14 was reached on 01/12/24, a 52-week low of $0.63 was recorded on 09/30/24. SMA at 50 days reached $0.8448, while 200 days put it at $1.5183.
Levels Of Support And Resistance For VOR Stock
The 24-hour chart illustrates a support level at 0.6272, which if violated will result in even more drops to 0.6101. On the upside, there is a resistance level at 0.6696. A further resistance level may holdings at 0.6949. The Relative Strength Index (RSI) on the 14-day chart is 31.52, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0153, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 91.55%. Stochastics %K at 15.17% indicates the stock is a buying.
How much short interest is there in Vor Biopharma Inc?
A steep rise in short interest was recorded in Vor Biopharma Inc stocks on 2024-09-30, growing by 0.41 million shares to a total of 1.97 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 1.56 million shares. There was a rise of 21.04%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 02, 2021 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $30 price target.
